Prodrox

In the US, Prodrox (hydroxyprogesterone systemic) is a member of the drug class progestins.

US matches:

• Prodrox

Ingredient matches for Prodrox

Hydroxyprogesterone

Hydroxyprogesterone caproate (a derivative of Hydroxyprogesterone) is reported as an ingredient of Prodrox in the following countries:

• United States

International Drug Name Search

Para Pio

Para Pio may be available in the countries listed below.

Ingredient matches for Para Pio

Piperonyl Butoxide

Piperonyl Butoxide is reported as an ingredient of Para Pio in the following countries:

• Portugal

International Drug Name Search

Flogocort

Flogocort may be available in the countries listed below.

Ingredient matches for Flogocort

Mometasone

Mometasone 17-(2-furoate) (a derivative of Mometasone) is reported as an ingredient of Flogocort in the following countries:

• Chile


• Ecuador


• Peru

International Drug Name Search

NAC-Hemofarm

NAC-Hemofarm may be available in the countries listed below.

Ingredient matches for NAC-Hemofarm

Acetylcysteine

Acetylcysteine is reported as an ingredient of NAC-Hemofarm in the following countries:

• Serbia

International Drug Name Search

Quinapril Helvepharm

Quinapril Helvepharm may be available in the countries listed below.

Ingredient matches for Quinapril Helvepharm

Quinapril

Quinapril hydrochloride (a derivative of Quinapril) is reported as an ingredient of Quinapril Helvepharm in the following countries:

• Switzerland

International Drug Name Search

Meomel

Meomel may be available in the countries listed below.

Ingredient matches for Meomel

Meloxicam

Meloxicam is reported as an ingredient of Meomel in the following countries:

• Greece

International Drug Name Search

Carteolol-Viatris

Carteolol-Viatris may be available in the countries listed below.

Ingredient matches for Carteolol-Viatris

Carteolol

Carteolol hydrochloride (a derivative of Carteolol) is reported as an ingredient of Carteolol-Viatris in the following countries:

• Luxembourg

International Drug Name Search

Dermklobal

Dermklobal may be available in the countries listed below.

Ingredient matches for Dermklobal

Clobetasol

Clobetasol 17α-propionate (a derivative of Clobetasol) is reported as an ingredient of Dermklobal in the following countries:

• Poland

International Drug Name Search

Troxerutin MK

Troxerutin MK may be available in the countries listed below.

Ingredient matches for Troxerutin MK

Troxerutin

Troxerutin is reported as an ingredient of Troxerutin MK in the following countries:

• Romania

International Drug Name Search

Duofilm Solution

Pronunciation: sal-ih-SILL-ik AS-id
Generic Name: Salicylic Acid
Brand Name: Examples include Dr. Scholl's Corn/Callous Remover and Duofilm

Duofilm Solution is used for:

Removing corns, calluses, and warts. It may also be used for other conditions as determined by your doctor.

Duofilm Solution is a topical salicylate. It works by causing the skin to swell, soften, and then slough or peel in areas where it is applied.

Do NOT use Duofilm Solution if:

• you are allergic to any ingredient in Duofilm Solution


• you have diabetes or poor blood circulation

Contact your doctor or health care provider right away if any of these apply to you.

Before using Duofilm Solution:

Some medical conditions may interact with Duofilm Solution. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have had a severe allergic reaction (eg, severe rash, hives, difficulty breathing, dizziness) to aspirin or a nonsteroidal anti-inflammatory drug (NSAID) (eg, ibuprofen, naproxen, celecoxib)


• if you have liver or kidney problems, a skin infection, or skin irritation

Some MEDICINES MAY INTERACT with Duofilm Solution. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Anticoagulants, (eg, heparin, warfarin), aspirin, methotrexate, or sulfonylureas (eg, glipizide) because the risk of side effects may be increased by Duofilm Solution

This may not be a complete list of all interactions that may occur. Ask your health care provider if Duofilm Solution may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Duofilm Solution:

Use Duofilm Solution as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• First soak the affected area in warm water for about 5 minutes. Dry thoroughly. Apply 1 drop at a time to sufficiently cover each affected area. Let dry.


• Cover the area with a small adhesive bandage or dressing (if practical) unless your doctor has instructed you not to. Unless your hands are being treated, be sure to wash your hands after each application.


• If you miss a dose of Duofilm Solution, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use Duofilm Solution.

Important safety information:

• Duofilm Solution is for external use only. Avoid getting Duofilm Solution in your eyes, nose, or mouth, or on the genitals. If contact with your eyes occurs, flush with water for 15 minutes. Do not inhale the vapors of Duofilm Solution.


• Do not use Duofilm Solution longer or more often than recommended by your doctor or on the package label.


• Check with your doctor before use if you have a condition that covers a large area of the body.


• Be sure to apply Duofilm Solution only to the affected area and not to normal healthy skin.


• Do not use Duofilm Solution on skin that is irritated, infected, or reddened.


• Do not use Duofilm Solution on open skin wounds, moles, birthmarks, genital warts, warts on the face, or warts growing hair.


• Do not use any other medicines or drying products on your skin unless your doctor instructs you otherwise.


• Duofilm Solution may interfere with certain lab test results. Make sure your doctor and lab personnel know you are using Duofilm Solution.


• Duofilm Solution is extremely flammable. Do not store or use Duofilm Solution near a fire or other open flame.


• Duofilm Solution may be harmful if swallowed. If you may have taken Duofilm Solution by mouth, contact your local poison control center or emergency room immediately.


• Duofilm Solution contains a salicylate, which has been linked to Reye syndrome. Do not use Duofilm Solution on children or teenagers during or after chickenpox, flu, or other viral infections without checking with your doctor or pharmacist.


• Caution is advised when using Duofilm Solution in CHILDREN because they may be more sensitive to its effects.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, discuss with your doctor the benefits and risks of using Duofilm Solution during pregnancy. It is unknown if Duofilm Solution is excreted in breast milk. If you are or will be breast-feeding while you are using Duofilm Solution, check with your doctor or pharmacist to discuss the risks to your baby.

Possible side effects of Duofilm Solution:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Dry, peeling, red, or scaling skin.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); severe irritation.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Duofilm side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include agitation; diarrhea; dizziness; loss of appetite; loss of hearing; mental disturbances; nausea; rapid or difficult breathing; ringing in the ears; seizures; sluggishness; vomiting; yellowing of the skin or eyes.

Proper storage of Duofilm Solution:

Store Duofilm Solution at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not freeze. Do not store in the bathroom. Keep Duofilm Solution out of the reach of children and away from pets.

General information:

• If you have any questions about Duofilm Solution, please talk with your doctor, pharmacist, or other health care provider.


• Duofilm Solution is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Duofilm Solution. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Duofilm resources

• Duofilm Side Effects (in more detail)
• Duofilm Use in Pregnancy & Breastfeeding
• Duofilm Drug Interactions
• Duofilm Support Group
• 0 Reviews for Duofilm - Add your own review/rating

Compare Duofilm with other medications

• Acne
• Warts

Toluene

In some countries, this medicine may only be approved for veterinary use.

CAS registry number (Chemical Abstracts Service)

0000108-88-3

Chemical Formula

C7-H8

Molecular Weight

92

Therapeutic Categories

Anthelmintic

Antiparasitic agent

Chemical Names

Methacide

Methylbenzene

Phenylmethane

Foreign Names

• Toluolum (Latin)
• Toluol (German)
• Tolueno (Spanish)

Generic Names

• CCRIS 2366 (IS)
• MePh (IS)
• NSC 406333 (IS)
• PhMe (IS)
• UNII-3FPU23BG52 (IS)

Brand Names

• Anaplex Caps (Toluene and Dichlorophen (veterinary use))
  Boehringer Ingelheim Vetmedica, United States



• Canine and Feline Wormer Caps (Toluene and Dichlorophen (veterinary use))
  Boehringer Ingelheim Vetmedica, United States



• D & T Worm Capsules (Toluene and Dichlorophen (veterinary use))
  Boehringer Ingelheim Vetmedica, United States



• Dichlorophen & Toluene Caps. (Toluene and Dichlorophen (veterinary use))
  Texas Vitamin, United States



• Difolin (Toluene and Dichlorophen (veterinary use))
  Fort Dodge Animale Health, United States



• Elite Dog & Cat Wormer (Toluene and Dichlorophen (veterinary use))
  RSR Laboratories, United States



• L.K. Worming Capsules For Dogs (Toluene and Dichlorophen (veterinary use))
  Church & Dwight, United States



• Pet-Worm-Caps (Toluene and Dichlorophen (veterinary use))
  K.C. Pharmacal, United States



• Pulvex Multipurpose Worm Caps (Toluene and Dichlorophen (veterinary use))
  Virbac, United States



• Tiny Tiger Worming Capsules For Cats (Toluene and Dichlorophen (veterinary use))
  Church & Dwight, United States



• Tri-Plex Worm Capsules (Toluene and Dichlorophen (veterinary use))
  Schering-Plough Animal Health, United States



• Trivermicide Worm Capsules (Toluene and Dichlorophen (veterinary use))
  Happy Jack, United States



• Vermiplex (Toluene and Dichlorophen (veterinary use))
  Schering-Plough Animal Health, United States



• Worm Capsules (Toluene and Dichlorophen (veterinary use))
  Farnam, United States



• Worming Capsules For Puppies, Small Dogs And Cats (Toluene and Dichlorophen (veterinary use))
  Church & Dwight, United States

International Drug Name Search

Glossary

IS	Inofficial Synonym

Click for further information on drug naming conventions and International Nonproprietary Names.

Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Inactivated Poliovirus Vaccine

Pronunciation: dif-THEER-ee-a/TET-a-nus/aye-SELL-yoo-ler per-TUS-is/hep-a-TYE-tis/POE-lee-oh-VYE-rus
Generic Name: Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Inactivated Poliovirus Vaccine
Brand Name: Pediarix

Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Inactivated Poliovirus Vaccine is used for:

Preventing diphtheria, tetanus, pertussis, hepatitis B, and polio infections in infants and children.

Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Inactivated Poliovirus Vaccine is a vaccine for diphtheria, tetanus, pertussis, hepatitis B, and polio. It works by helping the immune system to protect against these infections.

Do NOT use Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Inactivated Poliovirus Vaccine if:

• the patient is allergic to any ingredient in Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Inactivated Poliovirus Vaccine or to latex, yeast, neomycin, or polymyxin B


• the patient has had a severe allergic reaction (eg, severe rash, hives, difficulty breathing, dizziness) or other severe reaction (eg, coma, prolonged seizure) to a previous dose of Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Inactivated Poliovirus Vaccine or a similar vaccine


• the patient has untreated nervous system problems (eg, infantile spasms, uncontrolled seizures, coma)

Contact the patient's doctor or health care provider right away if any of these apply.

Before using Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Inactivated Poliovirus Vaccine:

Some medical conditions may interact with Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Inactivated Poliovirus Vaccine. Tell the patient's doctor or pharmacist if the patient has any medical conditions, especially if any of the following apply:

• if the patient is taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if the patient has allergies to medicines, foods, or other substances


• if the patient has developed any of the following within 48 hours after a previous pertussis-containing vaccine: high fever (greater than 105 degrees F [40.5 degrees C]) from an unknown cause, coma, or persistent crying (for more than 3 hours)


• if the patient has a history of seizures (with or without fever) within 3 days of a previous pertussis-containing vaccine


• if the patient has a fever, infection, or other current illness; has cancer; receives chemotherapy or radiation therapy; is very ill or weakened; or takes medicine that may weaken the immune system, such as immunosuppressants (eg, cyclosporine) or corticosteroids (eg, prednisone)


• if the patient has a history of nervous system problems (eg, seizures, infantile spasms, multiple sclerosis), Guillain-Barre syndrome, poor health, a weakened immune system (eg, HIV infection, AIDS), or bleeding problems (eg, hemophilia, low platelets)

Some MEDICINES MAY INTERACT with Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Inactivated Poliovirus Vaccine. Tell the patient's health care provider if the patient is taking any other medicines, especially any of the following:

• Anticoagulants (eg, warfarin) because the risk of bleeding may be increased


• Corticosteroids (eg, prednisone), immunosuppressants (eg, cyclosporine), medicines that may weaken the immune system, or medicines to treat cancer because they may decrease Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Inactivated Poliovirus Vaccine's effectiveness

This may not be a complete list of all interactions that may occur. Ask the patient's health care provider if Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Inactivated Poliovirus Vaccine may interact with other medicines that the patient takes. Check with the patient's health care provider before you start, stop, or change the dose of any medicine.

How to use Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Inactivated Poliovirus Vaccine:

Use Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Inactivated Poliovirus Vaccine as directed by the patient's doctor. Check the label on the medicine for exact dosing instructions.

• Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Inactivated Poliovirus Vaccine is usually given as an injection at the patient's doctor's office, hospital, or clinic.


• Do not use Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Inactivated Poliovirus Vaccine if it contains particles or a gel-like substance, is cloudy or discolored, or if the vial is cracked or damaged.


• It is very important to receive each vaccine as scheduled. Be sure to make a note of when each vaccine was given for the child's medical record.


• If the patient misses a dose of Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Inactivated Poliovirus Vaccine, contact the patient's doctor right away.

Ask the patient's health care provider any questions you may have about how to use Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Inactivated Poliovirus Vaccine.

Important safety information:

• Tell the patient's doctor or dentist that the patient has received Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Inactivated Poliovirus Vaccine before the patient receives any medical or dental care, emergency care, or surgery.


• Tell the patient's doctor if the patient will be receiving other vaccines.


• Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Inactivated Poliovirus Vaccine may not protect everyone who receives it from diphtheria, tetanus, pertussis, hepatitis, or polio. Discuss any questions or concerns with the patient's doctor.


• Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Inactivated Poliovirus Vaccine should not be used in INFANTS younger than 6 weeks of age or in CHILDREN who are 7 years of age or older; safety and effectiveness in these children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Inactivated Poliovirus Vaccine is not approved for use in adults. It is not known if Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Inactivated Poliovirus Vaccine can cause harm to the fetus. If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Inactivated Poliovirus Vaccine while you are pregnant. It is not known if Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Inactivated Poliovirus Vaccine is found in breast milk. If you are or will be breast-feeding and use Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Inactivated Poliovirus Vaccine, check with your doctor. Discuss any possible risks to your baby.

Possible side effects of Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Inactivated Poliovirus Vaccine:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Decreased appetite; drowsiness; fever; irritability or fussiness; minor pain, swelling, or redness at the injection site.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); joint pain or stiffness; numbness or tingling of the arms or legs; red, swollen, or blistered skin; seizure; severe or persistent fever, diarrhea, unusual drowsiness, stomach pain, or vomiting; severe or persistent irritability (eg, unusual crying, screaming, restlessness); shortness of breath; unresponsiveness.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.

Proper storage of Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Inactivated Poliovirus Vaccine:

Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Inactivated Poliovirus Vaccine is usually handled and stored by a health care provider. If you are using Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Inactivated Poliovirus Vaccine at home, store Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Inactivated Poliovirus Vaccine as directed by your pharmacist or health care provider. Protect from light. Keep Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Inactivated Poliovirus Vaccine out of the reach of children and away from pets.

General information:

• If you have any questions about Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Inactivated Poliovirus Vaccine, please talk with your doctor, pharmacist, or other health care provider.


• Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Inactivated Poliovirus Vaccine is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If the patient's symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Inactivated Poliovirus Vaccine. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Inactivated Poliovirus Vaccine resources

• Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Inactivated Poliovirus Vaccine Use in Pregnancy & Breastfeeding
• Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Inactivated Poliovirus Vaccine Drug Interactions
• Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Inactivated Poliovirus Vaccine Support Group
• 0 Reviews for Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Inactivated Poliovirus - Add your own review/rating

Compare Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Inactivated Poliovirus Vaccine with other medications

• Diphtheria Prophylaxis
• Haemophilus influenzae Prophylaxis
• Hepatitis B Prevention
• Pertussis Prophylaxis
• Poliomyelitis Prophylaxis
• Tetanus Prophylaxis

Broxyquinoline

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A07AX01,G01AC06,P01AA01

CAS registry number (Chemical Abstracts Service)

0000521-74-4

Chemical Formula

C9-H5-Br2-N-O

Molecular Weight

302

Therapeutic Category

Antiprotozoal agent, amebicide

Chemical Name

8-Quinolinol, 5,7-dibromo-

Foreign Names

• Broxyquinolinum (Latin)
• Broxyquinolin (German)
• Broxyquinoline (French)
• Broxiquinolina (Spanish)

Generic Names

• Broxichinolina (OS: DCIT)
• Broxyquinoline (OS: DCF)
• Broxichinolinum (IS)
• Diromo (IS)
• UCB 5055 (IS)

Brand Name

• Starogyn
  Leiras, Finland

International Drug Name Search

Glossary

DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Fluconazole MK

Fluconazole MK may be available in the countries listed below.

Ingredient matches for Fluconazole MK

Fluconazole

Fluconazole is reported as an ingredient of Fluconazole MK in the following countries:

• Aruba


• Barbados


• Cayman Islands


• Haiti

International Drug Name Search